Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of ¹⁸F-DCFPyL PET/CT with Comparison to Multiparametric MRI

Схожие документы

• Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of (18)F-DCFPyL PET/CT with Comparison to Multiparametric MRI
  по: Lindenberg, Liza, и др.
  Опубликовано: (2020)
• ¹⁸F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy
  по: Esther Mena, и др.
  Опубликовано: (2019)
• Prospective Evaluation of (18)F-DCFPyL PET/CT in Detection of High-Risk Localized Prostate Cancer: Comparison With mpMRI
  по: Gaur, Sonia, и др.
  Опубликовано: (2020)
• Simplified Methods for Quantification of ¹⁸F-DCFPyL Uptake in Patients with Prostate Cancer
  по: B.H.E. Jansen, и др.
  Опубликовано: (2019)
• An improved synthesis of the radiolabeled prostate-specific membrane antigen inhibitor, [¹⁸F]DCFPyL
  по: Hayden T. Ravert, и др.
  Опубликовано: (2016)